S
6833
vs
CAH
S
6833
CAH
Over the past 12 months, Sinco Pharmaceuticals Holdings Ltd has underperformed CAH, delivering a return of +1% compared to the CAH's +63% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
6833
CAH
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
S
Intrinsic Value
0.77
HKD
Undervaluation 77%
CAH
Intrinsic Value
305.25
USD
Undervaluation 30%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
S
|
Sinco Pharmaceuticals Holdings Ltd
HKEX:6833
|
0.18
HKD
|
|||||
|
Cardinal Health Inc
NYSE:CAH
|
213.99
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
6833, CAH
6833, CAH
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
S
|
Sinco Pharmaceuticals Holdings Ltd
Revenue
|
|||||||||||
|
|
Cardinal Health Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
6833, CAH
6833, CAH
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
S
|
Sinco Pharmaceuticals Holdings Ltd
HKEX:6833
|
|||||||||
|
|
Cardinal Health Inc
NYSE:CAH
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Sinco Pharmaceuticals Holdings Ltd
10.7%
CAH
3.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinco Pharmaceuticals Holdings Ltd | ||||
|
|
Cardinal Health Inc | ||||
Operating Margin
Sinco Pharmaceuticals Holdings Ltd
3.9%
CAH
1.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinco Pharmaceuticals Holdings Ltd | ||||
|
|
Cardinal Health Inc | ||||
Net Margin
Sinco Pharmaceuticals Holdings Ltd
1.7%
CAH
0.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinco Pharmaceuticals Holdings Ltd | ||||
|
|
Cardinal Health Inc | ||||
FCF Margin
Sinco Pharmaceuticals Holdings Ltd
-1.2%
CAH
2.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinco Pharmaceuticals Holdings Ltd | ||||
|
|
Cardinal Health Inc | ||||
ROE
Sinco Pharmaceuticals Holdings Ltd
5.1%
CAH
-56.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinco Pharmaceuticals Holdings Ltd | ||||
|
|
Cardinal Health Inc | ||||
ROA
Sinco Pharmaceuticals Holdings Ltd
1.8%
CAH
3.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinco Pharmaceuticals Holdings Ltd | ||||
|
|
Cardinal Health Inc | ||||
ROIC
Sinco Pharmaceuticals Holdings Ltd
8%
CAH
15.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinco Pharmaceuticals Holdings Ltd | ||||
|
|
Cardinal Health Inc | ||||
ROCE
Sinco Pharmaceuticals Holdings Ltd
12.1%
CAH
22.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinco Pharmaceuticals Holdings Ltd | ||||
|
|
Cardinal Health Inc | ||||
Solvency Comparison
S
Sinco Pharmaceuticals Holdings L...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
6833, CAH
6833, CAH
Performance By Year
6833, CAH
6833, CAH
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 6833 to other stocks
MCK
Mckesson Corp
More expensive
vs Sinco Pharmaceuticals Holdings...
COR
Cencora Inc
More expensive
vs Sinco Pharmaceuticals Holdings...
0HF3
Amerisourcebergen Corp
A
More expensive
vs Sinco Pharmaceuticals Holdings...
SIG
Sigma Healthcare Ltd
More expensive
vs Sinco Pharmaceuticals Holdings...
Select Stock to Compare
| US |
|
Mckesson Corp
NYSE:MCK
|
|
| US |
|
Cencora Inc
NYSE:COR
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
